• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微管稳定化的机制由土瓜酮 AJ 实现。

Mechanism of microtubule stabilization by taccalonolide AJ.

机构信息

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China.

Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Nat Commun. 2017 Jun 6;8:15787. doi: 10.1038/ncomms15787.

DOI:10.1038/ncomms15787
PMID:28585532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5467209/
Abstract

As a major component of the cytoskeleton, microtubules consist of αβ-tubulin heterodimers and have been recognized as attractive targets for cancer chemotherapy. Microtubule-stabilizing agents (MSAs) promote polymerization of tubulin and stabilize the polymer, preventing depolymerization. The molecular mechanisms by which MSAs stabilize microtubules remain elusive. Here we report a 2.05 Å crystal structure of tubulin complexed with taccalonolide AJ, a newly identified taxane-site MSA. Taccalonolide AJ covalently binds to β-tubulin D226. On AJ binding, the M-loop undergoes a conformational shift to facilitate tubulin polymerization. In this tubulin-AJ complex, the E-site of tubulin is occupied by GTP rather than GDP. Biochemical analyses confirm that AJ inhibits the hydrolysis of the E-site GTP. Thus, we propose that the β-tubulin E-site is locked into a GTP-preferred status by AJ binding. Our results provide experimental evidence for the connection between MSA binding and tubulin nucleotide state, and will help design new MSAs to overcome taxane resistance.

摘要

作为细胞骨架的主要组成部分,微管由αβ-微管蛋白异二聚体组成,已被认为是癌症化疗的有吸引力的靶点。微管稳定剂(MSA)促进微管蛋白的聚合并稳定聚合物,防止解聚。MSA 稳定微管的分子机制仍不清楚。在这里,我们报告了一个 2.05Å 的微管与新鉴定的紫杉烷结合位点 MSA 塔卡隆内酯 AJ 的复合物晶体结构。塔卡隆内酯 AJ 与β-微管蛋白 D226 共价结合。在 AJ 结合时,M 环发生构象移位,促进微管蛋白聚合。在这个微管-AJ 复合物中,微管的 E 位被 GTP 占据,而不是 GDP。生化分析证实 AJ 抑制 E 位 GTP 的水解。因此,我们提出 AJ 结合将β-微管蛋白的 E 位锁定在 GTP 优先状态。我们的结果为 MSA 结合与微管核苷酸状态之间的联系提供了实验证据,并将有助于设计新的 MSA 来克服紫杉烷耐药性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/849d71b459c9/ncomms15787-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/7296e83c9fd6/ncomms15787-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/98fc7d884cbb/ncomms15787-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/9b1ca6b70518/ncomms15787-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/849d71b459c9/ncomms15787-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/7296e83c9fd6/ncomms15787-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/98fc7d884cbb/ncomms15787-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/9b1ca6b70518/ncomms15787-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e135/5467209/849d71b459c9/ncomms15787-f4.jpg

相似文献

1
Mechanism of microtubule stabilization by taccalonolide AJ.微管稳定化的机制由土瓜酮 AJ 实现。
Nat Commun. 2017 Jun 6;8:15787. doi: 10.1038/ncomms15787.
2
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.塔卡隆内酯与微管蛋白结合赋予微管稳定性和强大的体内活性。
Cancer Res. 2013 Nov 15;73(22):6780-92. doi: 10.1158/0008-5472.CAN-13-1346. Epub 2013 Sep 18.
3
The determinants that govern microtubule assembly from the atomic structure of GTP-tubulin.从 GTP-微管蛋白的原子结构上控制微管组装的决定因素。
J Mol Biol. 2011 Sep 9;412(1):35-42. doi: 10.1016/j.jmb.2011.07.029. Epub 2011 Jul 23.
4
Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.强效的塔卡隆内酯 AF 和 AJ,提供了重要的结构活性关系和微管作为这些微管稳定剂结合位点的信息。
J Am Chem Soc. 2011 Nov 30;133(47):19064-7. doi: 10.1021/ja209045k. Epub 2011 Nov 8.
5
High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.三种微管稳定药物与微管蛋白复合物的高分辨率 X 射线结构为药物设计提供了依据。
Biochem Biophys Res Commun. 2021 Jan 1;534:330-336. doi: 10.1016/j.bbrc.2020.11.082. Epub 2020 Nov 30.
6
Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.采用组合化学方法阐明塔卡隆内酯共价微管稳定剂的靶标特异性。
Nat Commun. 2020 Jan 31;11(1):654. doi: 10.1038/s41467-019-14277-w.
7
Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.解析扎那米韦醇和塔卡醇 AJ 与人微管蛋白最小模型的共价结合。
J Comput Aided Mol Des. 2019 Jul;33(7):627-644. doi: 10.1007/s10822-019-00208-w. Epub 2019 May 31.
8
Molecular mechanism of action of microtubule-stabilizing anticancer agents.微管稳定剂类抗癌药物的作用机制。
Science. 2013 Feb 1;339(6119):587-90. doi: 10.1126/science.1230582. Epub 2013 Jan 3.
9
Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.扎马普隆(Zampanolide)是一种新型强效微管稳定剂,它能与微管蛋白α,β-异二聚体和微管中的紫杉烷腔位点发生共价反应。
Chem Biol. 2012 Jun 22;19(6):686-98. doi: 10.1016/j.chembiol.2012.05.008.
10
Concerning the chemical nature of tubulin subunits that cap and stabilize microtubules.关于帽化并稳定微管的微管蛋白亚基的化学性质。
Biochemistry. 2003 Feb 25;42(7):2122-6. doi: 10.1021/bi027010s.

引用本文的文献

1
Pharmacokinetic and Biodistribution Studies of [F]-Taccalonolide: A Covalent Microtubule Stabilizer with Antitumor Efficacy.[F] - 他卡洛内酯的药代动力学和生物分布研究:一种具有抗肿瘤功效的共价微管稳定剂
ACS Med Chem Lett. 2025 Jul 16;16(8):1569-1574. doi: 10.1021/acsmedchemlett.5c00208. eCollection 2025 Aug 14.
2
Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors.新型4-芳基-2-苯甲酰基咪唑作为秋水仙碱结合位点抑制剂的设计与合成
Eur J Med Chem. 2025 Nov 15;298:118021. doi: 10.1016/j.ejmech.2025.118021. Epub 2025 Aug 4.
3
Crosstalk between Microtubule Stabilizing Agents and Prostate Cancer.

本文引用的文献

1
Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.吡咯菌素与αCys316共价结合并扰乱α-微管蛋白的一个主要环和螺旋以抑制微管形成。
J Mol Biol. 2016 Jul 31;428(15):2981-8. doi: 10.1016/j.jmb.2016.06.023. Epub 2016 Jul 6.
2
Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.派罗尼丁与α-微管蛋白的半胱氨酸 316 发生共价反应,从而使微管不稳定。
Nat Commun. 2016 Jun 30;7:12103. doi: 10.1038/ncomms12103.
3
Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potency.
微管稳定剂与前列腺癌之间的相互作用
Cancers (Basel). 2023 Jun 23;15(13):3308. doi: 10.3390/cancers15133308.
4
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo.嘧啶二氢喹喔啉酮衍生物作为微管蛋白秋水仙碱位点结合剂的设计、合成及生物学评价,其在体外和体内均显示出强大的抗癌活性。
ACS Pharmacol Transl Sci. 2023 Mar 22;6(4):526-545. doi: 10.1021/acsptsci.2c00108. eCollection 2023 Apr 14.
5
Measuring the linear viscoelastic regime of MCF-7 cells with a monolayer rheometer in the presence of microtubule-active anti-cancer drugs at high concentrations.在高浓度微管活性抗癌药物存在的情况下,使用单层流变仪测量MCF-7细胞的线性粘弹性状态。
Interface Focus. 2022 Oct 14;12(6):20220036. doi: 10.1098/rsfs.2022.0036. eCollection 2022 Dec 6.
6
Taccalonolides: Structure, semi-synthesis, and biological activity.紫杉叶素内酯:结构、半合成及生物活性。
Front Pharmacol. 2022 Aug 11;13:968061. doi: 10.3389/fphar.2022.968061. eCollection 2022.
7
In Vivo Evaluation of (-)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site.体内评估 (-)- 扎那米韦内酯靶向肿瘤部位时表现出强大而持久的抗肿瘤疗效。
Molecules. 2022 Jul 1;27(13):4244. doi: 10.3390/molecules27134244.
8
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones.抗微管蛋白药物的耐药性:从长春花生物碱到埃坡霉素
Cancer Drug Resist. 2019 Mar 19;2(1):82-106. doi: 10.20517/cdr.2019.06. eCollection 2019.
9
Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy.多阶段 pH 响应型共载脂质体平台用于协同癌症治疗。
J Nanobiotechnology. 2022 Apr 2;20(1):177. doi: 10.1186/s12951-022-01383-z.
10
X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor.X射线晶体学引导设计、代谢稳定的环戊基嘧啶基二氢喹喔啉酮作为一种有效的微管蛋白聚合抑制剂的抗肿瘤功效及定量构效关系分析
J Med Chem. 2021 Sep 9;64(17):13072-13095. doi: 10.1021/acs.jmedchem.1c01202. Epub 2021 Aug 18.
合成反应与罕见的塔卡隆内酯揭示了 C-22,23 环氧化对于微管稳定效力的价值。
J Med Chem. 2014 Jul 24;57(14):6141-9. doi: 10.1021/jm500619j. Epub 2014 Jul 2.
4
High-resolution microtubule structures reveal the structural transitions in αβ-tubulin upon GTP hydrolysis.高分辨率微管结构揭示了 GTP 水解时 αβ-微管蛋白的结构转变。
Cell. 2014 May 22;157(5):1117-29. doi: 10.1016/j.cell.2014.03.053.
5
Taccalonolide microtubule stabilizers.他卡醇内酯类微管稳定剂。
Bioorg Med Chem. 2014 Sep 15;22(18):5091-6. doi: 10.1016/j.bmc.2014.01.012. Epub 2014 Jan 15.
6
Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.近年来微管稳定剂的研究进展:新化合物、结合模式和细胞活性。
Nat Prod Rep. 2014 Mar;31(3):335-55. doi: 10.1039/c3np70092e.
7
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.塔卡隆内酯与微管蛋白结合赋予微管稳定性和强大的体内活性。
Cancer Res. 2013 Nov 15;73(22):6780-92. doi: 10.1158/0008-5472.CAN-13-1346. Epub 2013 Sep 18.
8
Structural basis of tubulin tyrosination by tubulin tyrosine ligase.微管蛋白酪氨酸连接酶催化微管蛋白酪氨酸化的结构基础。
J Cell Biol. 2013 Feb 4;200(3):259-70. doi: 10.1083/jcb.201211017. Epub 2013 Jan 28.
9
Molecular mechanism of action of microtubule-stabilizing anticancer agents.微管稳定剂类抗癌药物的作用机制。
Science. 2013 Feb 1;339(6119):587-90. doi: 10.1126/science.1230582. Epub 2013 Jan 3.
10
Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.强效的塔卡隆内酯 AF 和 AJ,提供了重要的结构活性关系和微管作为这些微管稳定剂结合位点的信息。
J Am Chem Soc. 2011 Nov 30;133(47):19064-7. doi: 10.1021/ja209045k. Epub 2011 Nov 8.